Brief: Urogen Pharma Expands Executive Team To Accelerate Platform Innovation And Drive Commercial Growth
09/09/2020 13:27
Sept 9 (Reuters) - Urogen Pharma Ltd UR8.F :
* UROGEN PHARMA EXPANDS EXECUTIVE TEAM TO ACCELERATE
PLATFORM
INNOVATION AND DRIVE COMMERCIAL GROWTH
* UROGEN PHARMA LTD - MOLLY HENDERSON NAMED CHIEF FINANCIAL
OFFICER
Source text for Eikon: ID:nBw1Z75Sla
Further company coverage: UR8.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on UroGen Pharma
See all newsBrief: Urogen Submits NDA For Ugn-103, An Investigational Treatment Of Recurrent Lg-Ir-Nmibc
Reports 36-Month Duration Of Response Of 64.5% For ZUSDURI In Phase 3 Envision Trial
Brief: Journal Of Urology Publishes Envision Trial Results Showing 72.2% 24-Month Duration Of Response With Zusduri
Brief: Urogen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Urogen Announces Refinanced Term Loan Agreement With Pharmakon Advisors